The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness
Marcio S. C. Longo, Bheatrix Bienemann, Marco Multedo, Marco Aurélio Negreiros, Eduardo Ekman Schenberg, Daniel C Mograbi
Journal of Psychoactive Drugs August 19, 2022 DOI: 10.1080/02791072.2022.2112788 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Population | General population in Brazil |
| Topics | Ayahuasca Cannabis MDMA Psilocybin Serotonin |
| Keywords | Hallucinogen Population Analysis of variance Psychoactive substance Clinical psychology Association psychology Environmental health Psychotherapist |
| Citations | 10 |
| Key findings | Only ayahuasca/DMT past and current use remained positively associated with nature relatedness after controlling for sociodemographic variables. |
Abstract
This study sought to investigate the effects of different substances on nature relatedness (NR) in the general population. An online cross-sectional survey done in Brazil investigated use of ayahuasca/DMT, psilocybe mushrooms, LSD, MDMA/ecstasy, cocaine, cannabis, and alcohol. NR was assessed using the short-form version of the nature related scale (NR-6). One-way analysis of variance (ANOVA) was used to assess group differences between substance naïve-individuals, past users, and current users of each substance. Regression models were used including all the substances and subsequently, sociodemographic variables. ANOVAs with substances which showed significantly higher NR-6 scores in the regression model were used in order to assess the effect of intention of future use on NR. ANOVAs indicated higher NR in users of classic serotonergic psychedelics (ayahuasca/DMT, psilocybe mushrooms, LSD), cannabis, and MDMA/ecstasy. Regression models showed that current use of ayahuasca/DMT and psilocybe mushrooms, and past use of LSD had a positive association with NR. When sociodemographic variables were added, only ayahuasca/DMT past and current use were positively associated with NR. Intention of future use was only significantly associated with NR in individuals who reported intention of future use of psilocybe mushrooms.
Comparable studies
Other cross-sectional and survey studies on serotonin, most cited first.
Citations in the library
Cited by 10
- Ayahuasca: A review of historical, pharmacological, and therapeutic aspects. Psychiatry and Clinical Neurosciences Reports December 1, 2023
- Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness Journal of Psychopharmacology 2023
- Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study. Journal of Psychoactive Drugs 2025
- Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment Frontiers in Psychiatry December 19, 2023
- Psychedelics and connectedness to natural and social worlds: An examination of the evidence and a proposed conceptual framework. Current Opinion in Psychology April 1, 2025
and 5 more in the library
Cites 26
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
and 21 more in the library